Although there are many prospective targets in the tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSOC), pre-clinical testing is challenging especially as there is limited informat

NIAID Data Ecosystem50

microRNA alterations associated to clinical response in advanced stage ovarian cancer patients

卵巢癌生物标志物

MicroRNA表达

microRNA alterations associated to clinical response in advanced stage ovarian cancer patients

ChEBI2012-03-09 更新20

Gut microbiomes of patients under cancer immunotherapy Raw sequence reads. Gut microbiomes of patients under cancer immunotherapy

癌症免疫治疗微生物组

治疗反应预测

Gut microbiomes have been linked to the clinical responses of oncology patients on immunotherapies. Further investigation into potential gut microbiome biomarkers of immunotherapy response may improve

NIAID Data Ecosystem50

Table_1_Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy.xls

三阴性乳腺癌预后

治疗反应预测

BackgroundInflammation is one of the most important characteristics of tumor tissue. Signatures based on inflammatory response-related genes (IRGs) can predict prognosis and treatment response in a va

NIAID Data Ecosystem30

microRNA alterations associated to clinical response in advanced stage ovarian cancer patients (test set)

资源简介：

相关数据集